News Articles

Thursday Mar 02, 2023 - 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Nano-sized Molecules Show Powerful Impact in Preclinical Studies

BiondVax Pharmaceuticals is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company’s alpaca-derived nanosized antibodies (“NanoAbs”) exhibit superior valuable competitive advantages over commercially available monoclonal antibodies (“mAbs”), including better specificity and affinity to the target, hyper-thermostability, and potential for more effective and convenient routes of administration Preclinical in vivo data have shown its lead drug candidate, the inhaled anti-SARS-CoV-2 NanoAb,…

Wednesday Mar 01, 2023 - 11:15 am

GeoSolar Technologies Inc.’s Home Renewable Energy Solutions Protect Owners from Price Shocks as Subsidies Reach Record Levels

The International Energy Agency predicts global energy subsidies topped record high of $1 trillion in 2022, contributing to incorrect price signaling, market distortion, rising government spending, discourage renewable energy adoption GeoSolar develops whole home renewable energy solutions that can help insulate building owners from price shocks, contribute to energy independence SmartGreen(TM) Home system comprises geothermal ground loops, photovoltaic solar panels, integrated air ducts and floor…

Wednesday Mar 01, 2023 - 10:30 am

Prime Harvest Inc. Reveals That Their Reg A+ Equity Offering Has Been Granted Approval to Go Ahead

Prime Harvest recently revealed that the company’s Reg A+ equity offering has been greenlighted by the SEC The primary share offering will see the company market up to 10 million shares to investors at a price of $4.20 each, with estimated gross proceeds of $42 million The company has said that net proceeds will be destined towards the acquisition of licensed assets, continued expansion of…

Wednesday Mar 01, 2023 - 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Product and Business Updates, Including AI/Machine Learning Offering and Expansion of Quantum Cloud Service to Israel

D-Wave’s Leap(TM) cloud service will soon be available in 39 countries, including Israel, and will be accessible directly from D-Wave or AWS Marketplace The company is also expanding its feature selection offering, a fundamental part of machine learning, which has already shown promising results among customers in areas such as fraud detection and TV advertising optimization D-Wave also shared an update to its balance sheet…

Wednesday Mar 01, 2023 - 9:00 am

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Kicks Off New Year with New Look

Corporate rebrand, launch designed to reflect the company’s global mission CISO Global was founded to bring cybersecurity professionals together on a global basis Organizations spent around $150 billion in 2021 on cybersecurity, growing by 12.4% annually and creating a significant opportunity Cerberus Cyber Sentinel (NASDAQ: CISO) is starting off the new year with a new name, brand and logo (https://ibn.fm/Mxai7). The company, which has established…

Tuesday Feb 28, 2023 - 12:30 pm

Xponential Fitness, Inc. (NYSE: XPOF) Featured in Coverage of the 35th Annual Roth Conference

Xponential Fitness (NYSE: XPOF) is the largest global franchisor of boutique fitness brands. Through its mission to make boutique fitness accessible to everyone, the company operates a diversified platform of ten brands spanning across verticals including Pilates, indoor cycling, barre, stretching, rowing, dancing, boxing, running, functional training and yoga. In partnership with its franchisees, Xponential Fitness offers energetic, accessible, and personalized workout experiences led by…

Tuesday Feb 28, 2023 - 12:00 pm

Cingulate Inc. (NASDAQ: CING) Featured in Coverage of the 35th Annual Roth Conference

Cingulate (NASDAQ: CING), is a biopharmaceutical company utilizing its proprietary PTR(TM) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of ADHD, Cingulate is identifying and evaluating additional therapeutic areas where…

Tuesday Feb 28, 2023 - 11:15 am

Alternative Products Expo at Ft. Lauderdale, Coming Up Soon

The Alternatives Products Expo, organized by ZJ Events is being held in Fort Lauderdale March 3-5, 2023. Exhibitors can showcase their products and market their innovative ideas in front of a large audience of potential investors. This premier counterculture show will feature a diverse range of products including CBD, DELTA-8, Nicotine Alternatives, Kratom, Extracts, Functional Beverages, and more. The Alternative Products Expo will offer participants…

Tuesday Feb 28, 2023 - 10:30 am

Coyuchi Inc. Textiles Deliver Colors That Give Their Bed and Bath Lineup a Natural Home Feel and Intense Consumer Appeal, One of Several Factors Driving the Company’s Success

Bed and bath lifestyle brand Coyuchi Inc. delivers comfortable and renowned luxury textile all-organic products that are renowned for their look, feel, and luxury appeal The company’s sustainable living standard includes a traceable supply chain and a 2nd Home Take Back(TM) platform that gives new life to returned items An important element of Coyuchi’s popularity is the company’s sense and incorporation of color trends, providing…

Tuesday Feb 28, 2023 - 9:45 am

REZYFi, Inc. Delivers on Promise of Expertise, Focusing on Loan Origination and Support for Cannabis, High-risk Clients

Specialized mortgage lender REZYFi Inc. is strategically serving the needs of consumers and cannabis-related businesses through an alternative loan financing approach The company’s alternative mortgage financing strategy relies on real estate and other assets of the borrowers to secure loans for clients whose financial history or legal revenue base may make them unattractive borrowers for traditional banks The cannabis industry has long struggled to secure…

Tuesday Feb 28, 2023 - 9:00 am

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) ZVS Inverter to Benefit OEMs and End Users Alike as Inverters Prove Crucial for EV Efficiency

For some EV owners, charging may cost more than filling up, highlighting the need for enhancing EV efficiency – a metric that relies heavily on the productivity of their complex powertrain system Performance of powertrain components directly affects cost, driving range, charge time, and overall driving experience; as a result, inverter technology could determine the speed and success of EV adoption Hillcrest's proprietary ZVS inverter…

Monday Feb 27, 2023 - 12:00 pm

Corporation Logins, Password Breach, Highlights Importance of Cybersecurity Solutions Provided by SideChannel Inc. (SDCH)

Recently discovered cybercriminal activity included breaches at companies that provide third-party data services to corporate giants including Amazon, Apple, Microsoft and Walmart The breaches are feared to have exposed logins and passwords that could allow someone to masquerade as an employee and implant malware Cybersecurity services and technology provider SideChannel helps companies prevent or mitigate damage from such cyber attacks through the use of virtual…

Monday Feb 27, 2023 - 11:15 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Lays Groundwork to Capitalize on Opportunities in the Copper Industry Through Subsidiary McEwen Copper

Copper is well known for its growing demand in many industries, including renewable energy sources required for net-zero carbon emission goals implemented by over 70 countries The copper market is now expected to reach $446.7 billion by 2030, growing from $291.1 billion in 2021 McEwen Mining is a 68% shareholder in McEwen Copper’s Los Azules project, giving it 100% interest in what could soon become…

Monday Feb 27, 2023 - 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Additional HYPER-H21-4 Study Findings Offer Better Understanding of the Anti-Hypertensive Effects of DehydraTECH-CBD

Dosing for Lexaria’s ambitious and most comprehensive clinical study, HYPER-H21-4, was successfully completed in July 2022, with newly analyzed results now emerging Its latest findings bring the company closer to its upcoming FDA Phase 1b study while also explaining the patented DehydraTECH-(TM)-processed CBD interaction with the sympatho-chromaffin system via catestatin modulation Lexaria’s management is optimistic that DehyraTECH-CBD and its effectiveness in modulating catestatin levels could…

Monday Feb 27, 2023 - 9:45 am

Data443 Risk Mitigation Inc. (ATDS) Well Positioned Amid Growing Concerns About Cyber Security and Data Protection Practices

A fast-moving ransomware strike recently infected servers made by California-based cloud computing giant, VMWare, leveraging known vulnerabilities previously disclosed by this software company Ransomware continues to be one of the top digital threats and the problem is exacerbated by poor cybersecurity practices, such as lapses in adequate vulnerability management The attack is the last in a series of reminders that businesses need reliable cybersecurity systems…

Monday Feb 27, 2023 - 9:00 am

Freight Technologies Inc. (NASDAQ: FRGT) Jumps Revenue Guidance for 2023 Amid New Optimism for Commercial Truck Transport, Tracking Tools

B2B marketplace builder Freight Technologies Inc. is an innovator in resources for strengthening commercial supply chain transports between the United States, Canada and Mexico Freight Technologies, also known as Fr8Tech, has developed its AI-powered Fr8App resource to provide shippers and carriers with the tools they need for monitoring shipments and vehicle performance, and improving efficiency In this month’s State of the Union address, President Joe…

Friday Feb 24, 2023 - 11:15 am

Web3 Toronto To Explore The World Of Metaverse and Blockchain

The Web3 Toronto Summit, which will be held from March 1-2, 2023, invites entrepreneurs, investors, professionals, collaborators, and enthusiasts of the Metaverse, blockchain and Web3 spectrum, to participate in a robust networking and business opportunity for the Web3 community in Canada and beyond. With Web3 and other evolving technologies growing by leaps and bounds, the Web 3 Toronto Summit will serve as a meaningful initiative…

Friday Feb 24, 2023 - 10:30 am

GeoSolar Technologies Inc. Set to Benefit from the DOE’s Investments in Geothermal Energy

The Department of Energy recently agreed on a $74 million funding initiative aimed at 7 pilot projects exploring different methods of harnessing geothermal energy Geothermal energy currently generates 3.7 billion kilowatts per annum of electricity in the United States – enough to power 2.5 million homes GeoSolar Technologies has been an early mover within the geothermal technology space, using the renewable energy source as the…

Friday Feb 24, 2023 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Customer Engagements and Cross-Platform Product Enhancements During Qubits 2023 Convention

D-Wave’s Qubits annual user conference, currently in its seventh year, is one of the industry’s premier quantum computing events differentiated by its focus on real-world applications of quantum technology The company displayed its continued commercial customer momentum and real-time product innovation, reflecting the increasing enterprise adoption of quantum computing solutions The conference demonstrated how D-Wave’s proprietary technology helps organizations solve highly complex business problems today…

Friday Feb 24, 2023 - 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) and Its Collaborators Are Positioned to Rapidly Develop COVID-19 Treatments to Neutralize Emerging Variants

BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company primarily targets infectious diseases and autoimmune diseases, with its lead candidate, an inhaled COVID-19 NanoAb therapy, the subject of preclinical studies So far, the preclinical studies have shown that the NanoAb results in significantly milder illness and faster recovery, eliminates the SARS-CoV-2 virus from the lungs, and prevents illness…

Thursday Feb 23, 2023 - 12:00 pm

DX3 Canada – The Retail, Marketing And Technology Summit of 2023

The DX3 Canada, the largest and most impactful retail, technology, and marketing Summit, is being held on March 1-2, 2023. Experts, consultants, and marketing executives from the retail, marketing and tech industries, will offer their direction and guidance on important aspects of the retail, digital and marketing sectors in Canada and beyond. DX3 is a leading event management enterprise, organizing summits and trade shows that…

Thursday Feb 23, 2023 - 11:15 am

SideChannel Inc. (SDCH) Reports 48% Year-over-Year Revenue Growth in Q1 2023 Amid Continued Progress in Building vCISO Relationships with Clients and an Increase in Products and Services

SideChannel recently released its financial results for Q1 2023, recognizing $1,546,000 in revenue, a 48% year-over-year increase The company also ended the fiscal quarter with $2,553,000 in cash, having spent about $480,000 to offset R&D and marketing expenses SideChannel is in the business of providing cybersecurity leadership and program development through its team of virtual Chief Information Security Officers (“vCISOs”) The company has also developed…

Thursday Feb 23, 2023 - 10:30 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) CEO Joins Investor Webinar, Details Corporate Expansion Plans

EverGen Infrastructure CEO, Chase Edgelow recently joined a webinar hosted by Adelaide Capital to provide investors and stakeholders with an update on the company’s operations Edgelow elaborated on the company’s portfolio, including its 4 existing revenue generating assets, 2 projects currently under construction as well as its Ontario-based Greenfield project, Project Radius By 2Q 2023, EverGen anticipated that the completion of its RNG projects would…

Thursday Feb 23, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes…

Thursday Feb 23, 2023 - 9:00 am

USMCA Developed to Bolster North American Export Services, with Freight Technologies Inc. (NASDAQ: FRGT) to Capitalize on It

Export services under NAFTA, mainly covering transportation, travel, business, and financial services, increased from $14.7 billion in 1999 to $30.4 billion in 2021 With the transition from NAFTA to USMCA, trade in goods and services is set to see a spike from 2022 going forward, and Fr8Tech expects to capitalize on this Freight Technologies Inc., with its superior freight platform for North American cross-border shipping,…

Wednesday Feb 22, 2023 - 2:00 pm

Ocuphire Pharma, Inc. (NASDAQ: OCUP) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Ocuphire Pharma (NASDAQ: OCUP) is a publicly traded, clinical-stage, ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of refractive and retinal eye disorders. Ocuphire has a previously disclosed pharma partnership to develop and commercialize Nyxol(R) eye drops as a preservative-free eye drop formulation of phentolamine mesylate, a non-selective alpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size by uniquely blocking…

Wednesday Feb 22, 2023 - 1:30 pm

Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference

Sernova (TSX: SVA) is a clinical-stage biotechnology company developing therapeutic cell technologies with a goal to deliver a 'functional cure' for chronic diseases, including insulin-dependent diabetes, thyroid disease and hemophilia A. Sernova has developed the Cell Pouch System(TM), an implantable, scalable, and retrievable medical device which forms a natural environment for long-term survival and function of immune-protected therapeutic cells. In Sernova's T1D clinical program, the…

Wednesday Feb 22, 2023 - 1:00 pm

D-Wave Quantum Inc. (NYSE: QBTS) Featured in Coverage of the 35th Annual Roth Conference

D-Wave Quantum (NYSE: QBTS) is a leader in the development and delivery of quantum computing systems, software, and services, and is the world's first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. Their mission is to unlock the power of quantum computing today to benefit business and society. They do this by delivering customer value with…

Wednesday Feb 22, 2023 - 12:30 pm

Powerfleet Inc. (NASDAQ: PWFL) Featured in Coverage of the 35th Annual Roth Conference

Powerfleet (NASDAQ: PWFL) is a global leader of internet of things (“IoT”) software-as-a-service (“SaaS”) solutions that optimize the performance of mobile assets and resources to unify business operations. Powerfleet Unity, our fleet intelligence platform, ingests, processes, and enriches data from every vehicle, asset, and person – powering artificial-intelligence insights to transform the way our customers do business. Purpose-built to empower businesses around the world, our…

Wednesday Feb 22, 2023 - 12:00 pm

Genenta Science (NASDAQ: GNTA) Featured in Coverage of the 35th Annual Roth Conference

Genenta (NASDAQ: GNTA) is a clinical-stage biotechnology company engaged in the development of a proprietary hematopoietic stem cell gene therapy for the treatment of a variety of solid tumor cancers. Temferon(TM) is based on ex-vivo gene transfer into autologous Tie2+ hematopoietic stem/progenitor cells (“HSPCs”) to deliver immunomodulatory molecules directly via tumor-infiltrating monocytes/macrophages (Tie2 Expressing Monocytes - TEMs). Temferon(TM), which is under investigation in a phase…

Wednesday Feb 22, 2023 - 11:15 am

Alternative Products Expo Announces Its Upcoming Fort Lauderdale 2023 Show

Alternative Products Expo has just announced its next show, which will take place on March 3-5, 2023, in the beautiful city of Fort Lauderdale, Florida. This one-of-a-kind trade show promises to provide attendees with a unique experience that breaks away from the monotony of traditional events. It's a must-attend for anyone in the smoke shop and counterculture industry. Known for short as Alt Pro Expo,…

Wednesday Feb 22, 2023 - 10:30 am

The 3rd Annual Mining Journal Select Event: Exceptional Investment Opportunities Selected By Mining Journal

Institutional and professional investors as well as mining experts, businesses, and professionals are invited to attend the Mining Journal Select Show on March 27-28th, 2023. An exclusive lineup of presenters will pitch their businesses in front of industry leaders and investors and get an opportunity for one-on-one meetings and personalized discussions with these eminent investment groups. These mining companies presenting at Mining Journal Select are…

Wednesday Feb 22, 2023 - 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug…

Wednesday Feb 22, 2023 - 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) NanoAb Product Shows Preclinical Promise as COVID Preventative for consumers Hit by Evusheld’s EUA Withdrawal

BiondVax Pharmaceuticals is promoting preclinical results of its lead “biobetter” NanoAb drug candidate for conveniently proactively preventing COVID The company’s CEO recently presented the data at the annual BIO CEO & Investor Conference in New York, as well as updates on the company’s pipeline for treating autoimmune diseases such as psoriasis, asthma, psoriatic arthritis and macular degeneration Monoclonal antibody-based drug product Evusheld recently lost its…

Tuesday Feb 21, 2023 - 1:30 pm

The 3rd Annual Winter Wonderland Best Ideas Conference Being Hosted by MicroCap Rodeo as a Virtual Event

Investors, small-cap and micro-cap businesses are invited to attend the virtual edition of the MicroCap Rodeo’s 3rd Annual Winter Wonderland Best Ideas Conference. The event, being organized in association with Issuer Direct, will be held Feb. 21-24, 2023. The conference format is designed based on the successful implementation of the last eight conferences which were a mix of in-person as well as virtual events. The…

Tuesday Feb 21, 2023 - 12:45 pm

Technologies from Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Offer Step Change Improvements Across the Electrification Spectrum

Adoption of zero-emission vehicles accelerated across almost all markets and vehicle segments in 2022 and will continue on the back of increasing government regulation and incentives Power inverters, irreplaceable power conversion tech, has received a meaningful upgrade with Hillcrest’s ZVS inverter technology that improves operating power and efficiency Hillcrest anticipates commitments for commercial revenue this year from its inverter as it expands into multiple other…

Tuesday Feb 21, 2023 - 12:00 pm

HeartBeam Inc. (NASDAQ: BEAT) Supports American Heart Month with Commitment to Provide Solutions

President Biden proclaims February as American Heart Month Annual tradition provides opportunity to focus on nationwide problem of heart and blood-vessel diseases HeartBeam is committed to being part of the solution for identifying, treating heart attacks Following a decades-long tradition, President Joseph Biden issued a proclamation from the White House declaring February as American Heart Month (https://ibn.fm/6Z9Iq). This nationwide focus on heart health is fully…

Tuesday Feb 21, 2023 - 11:15 am

Coyuchi Inc. Preparing to Enter a New Phase of Growth Through Sustainability and Circular Design

Coyuchi, the gold standard in sustainable luxury home goods, has not only pushed the sustainability conversation forward but also lived it in all of its operations Its unique market positioning has seen its net income grow by 26% YOY between 2020 and 2021, with a return customer rate of 35% over 24 months The company’s management is optimistic that 2023 will be a great year,…

Tuesday Feb 21, 2023 - 10:30 am

REZYFi, Inc. Stands Ready to Provide Much-Needed Capital to Cannabis Companies as Softening Mortgage Rates Boost Opportunities for Refinancing

REZYFi is a real estate-oriented mortgage company servicing the needs of licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies The average rate on a 30-year-fixed-rate mortgage, measured weekly, has been declining gradually since October last year, increasing the market for new and refinanced mortgages Mortgage refinancing can be a source of capital, presenting an important financing opportunity for…

Tuesday Feb 21, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Foster New Partnerships with its Expanding DehydraTECH(TM) Licensing Opportunities

Lexaria’s patented DehydraTECH(TM) technology improves how APIs enter the bloodstream through the promotion of healthier oral ingestion methods while also increasing the effectiveness of fat-soluble active molecules As a disruptive technology, its impact has been felt by other players in its space, leading Lexaria to open its doors to partnering with industry experts and implementing the technology across many fields, including licensing the technology to…

Articles

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions